Literature DB >> 777023

Metoclopramide stimulates prolactin secretion in man.

R W McCallum, J R Sowers, J M Hershman, R A Sturdevant.   

Abstract

Serum prolactin concentrations increased approximately 6-fold after oral or intravenous administration of 10 mg of metoclopramide to adult men. Prolactin remained significantly elevated up to 9 h after oral metoclopramide and for at least 2 h after iv metoclopramide. Bethanechol did not increase serum prolactin, and atropine did not inhibit metoclopramide-induced prolactin elevation, suggesting that the cholinergic-like properties of metoclopramide were not responsible for the observed prolactin responses. Pre-treatment with 500 mg L-dopa inhibited the early metoclopramide-induced prolactin increase, which is consistent with the possibility that metoclopramide acts by inhibiting dopamine-mediated hypothalamic secretion of prolactin inhibitory factor. As a potent stimulus of prolactin release, metoclopramide may be useful in clinical investigation of hypothalamic-pituitary function.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 777023     DOI: 10.1210/jcem-42-6-1148

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  Metoclopramide hydrochloride and galactorrhea.

Authors:  W A Finnis; C E Bird; D L Wilson
Journal:  Can Med Assoc J       Date:  1976-11-06       Impact factor: 8.262

Review 2.  Gender dimorphism in immune responses following trauma and hemorrhage.

Authors:  Yukihiro Yokoyama; Martin G Schwacha; T S Anantha Samy; Kirby I Bland; Irshad H Chaudry
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 3.  Neuroendocrine causes of amenorrhea--an update.

Authors:  Lindsay T Fourman; Pouneh K Fazeli
Journal:  J Clin Endocrinol Metab       Date:  2015-01-12       Impact factor: 5.958

4.  [New aspects in the antiemetic therapy of cytostatic drug-induced vomiting].

Authors:  E Hiller; H Gerhartz
Journal:  Klin Wochenschr       Date:  1984-05-15

5.  Lithium increases 5-HT-mediated prolactin release.

Authors:  S L McCance; P R Cohen; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Pharmacokinetic and concentration-effect studies with intravenous metoclopramide.

Authors:  D N Bateman; C Kahn; K Mashiter; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

7.  L-Dopa inhibits metoclopramide stimulation of the lower esophageal sphincter in man.

Authors:  H W Baumann; A L Sturdevant; R W McCallum
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

8.  Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.

Authors:  R M Carey; M O Thorner; E M Ortt
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

9.  Flunarizine increases PRL secretion in normal and in migraineous women.

Authors:  U Bonuccelli; P Piccini; A M Paoletti; A Nuti; A Colzi; G B Melis; A Muratorio
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

10.  Oxytocin does not modify the prolactin response to metoclopramide in normal women.

Authors:  P Chiodera; R Volpi; D Gramellini; C Cigarini; A Corradi; U Cavazzini; L Bianconi; C Papadia; A Caiazza; L Capretti
Journal:  J Endocrinol Invest       Date:  1991-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.